nach oben

Erschienen in:

04.11.2017

Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004–2013

verfasst von: Christine M. Mauro, Paul Newswanger, Julian Santaella-Tenorio, Pia M. Mauro, Hannah Carliner, Silvia S. Martins

Erschienen in: Prevention Science | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

In states that have passed medical marijuana laws (MMLs), marijuana use (MU) increased after MML enactment among people ages 26 and older, but not among ages 12–25. We examined whether the age-specific impact of MMLs on MU varied by gender. Data were obtained from the 2004–2013 restricted-use National Survey on Drug Use and Health, aggregated at the state level. The exposure was a time-varying indicator of state-level MML (0 = No Law, 1 = Before Law, 2 = After Law). Outcomes included past-month MU prevalence, daily MU prevalence among past-year users (i.e., 300+ days/year), and past-year marijuana use disorder (MUD) prevalence. Linear models tested the state-level MML effect on outcomes by age (12–17, 18–25, 26+) and gender. Models included a state-level random intercept and controlled for time- and state-level covariates. Past-month MU did not increase after enactment of MML in men or women ages 12–25. Among people 26+, past-month MU increased for men from 7.0% before to 8.7% after enactment (+ 1.7%, p < 0.001) and for women from 3.1% before to 4.3% after enactment (+ 1.1%, p = 0.013). Among users 26+, daily MU also increased after enactment in both genders (men 16.3 to 19.1%, + 2.8%, p = 0.014; women 9.2 to 12.7%, + 3.4%, p = 0.003). There were no statistically significant increases in past-year MUD prevalence for any age or gender group after MML enactment. Given the statistically significant increase in daily use among past-year users aged 26+ following enactment, education campaigns should focus on informing the public of the risks associated with regular marijuana use.

Nur mit Berechtigung zugänglich

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association.

Anderson, D. M., Hansen, B., & Rees, D. I. (2013). Medical marijuana laws, traffic fatalities, and alcohol consumption. Journal of Law and Economics, 56, 333–369.CrossRef

Anderson, D. M., Hansen, B., & Rees, D. I. (2015). Medical marijuana laws and teen marijuana use. American Law and Economics Review, 17, 495–528.CrossRef

Bachhuber, M. A., Saloner, B., Cunningham, C. O., & Barry, C. L. (2014). Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Internal Medicine, 174, 1668–1673.CrossRefPubMedPubMedCentral

Budney, A. J., Roffman, R., Stephens, R. S., & Walker, D. (2007). Marijuana dependence and its treatment. Addiction Science & Clinical Practice, 4, 4–16.CrossRef

Carliner, H., Mauro, P. M., Brown, Q. L., Shmulewitz, D., Rahim-Juwel, R., Sarvet, A. L., et al. (2017). The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002–2014. Drug and Alcohol Dependence, 170, 51–58.CrossRefPubMed

Cerdá, M., Wall, M., Keyes, K. M., Galea, S., & Hasin, D. (2012). Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug and Alcohol Dependence, 120, 22–27.CrossRefPubMed

Choo, E. K., Benz, M., Zaller, N., Warren, O., Rising, K. L., & McConnell, K. J. (2014). The impact of state medical marijuana legislation on adolescent marijuana use. The Journal of Adolescent Health, 55, 160–166.CrossRefPubMed

Chromy, J.R., Abeyasekera, S. (2005). Statistical analysis of survey data. In United Nations Publications (Ed.), Household Sample Surveys in Developing and Transition Countries, Series96, 389–417. Retrieved from: https://unstats.un.org/unsd/hhsurveys/pdf/Household_surveys.pdf. Accessed 15 July 2015.

Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016). Marijuana use and use disorders in adults in the USA, 2002-14: Analysis of annual cross-sectional surveys. Lancet Psychiatry, 3, 954–964.CrossRefPubMed

Copeland, J., & Swift, W. (2009). Cannabis use disorder: Epidemiology and management. International Review of Psychiatry, 21, 96–103.CrossRefPubMed

Davis, G. P., Compton, M. T., Wang, S., Levin, F. R., & Blanco, C. (2013). Association between cannabis use, psychosis, and schizotypal personality disorder: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophrenia Research, 151, 197–202.CrossRefPubMed

de Boor, C. (Ed.). (1978). A practical guide to splines. New York: Springer-Verlag.

Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., et al. (2015). Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: A case-control study. Lancet Psychiatry, 2, 233–238.CrossRefPubMed

Fairman, B. J. (2016). Trends in registered medical marijuana participation across 13 US states and District of Columbia. Drug and Alcohol Dependence, 159, 72–79.CrossRefPubMed

Fergusson, D. M., Horwood, L. J., & Beautrais, A. L. (2003). Cannabis and educational achievement. Addiction, 98, 1681–1692.CrossRefPubMed

Gerberich, S. G., Sidney, S., Braun, B. L., Tekawa, I. S., Tolan, K. K., & Quesenberry, C. P. (2003). Marijuana use and injury events resulting in hospitalization. Annals of Epidemiology, 13, 230–237.CrossRefPubMed

Grotenhermen, F., Leson, G., Berghaus, G., Drummer, O. H., Kruger, H. P., Longo, M., et al. (2007). Developing limits for driving under cannabis. Addiction, 102, 1910–1917.CrossRefPubMed

Hall, W. (2009). The adverse health effects of cannabis use: What are they, and what are their implications for policy? International Journal of Drug Policy, 20, 458–466.CrossRefPubMed

Hall, W., & Degenhardt, L. (2009). Adverse health effects of non-medical cannabis use. Lancet, 374, 1383–1391.CrossRefPubMed

Harper, S., Strumpf, E., & Kaufman, J. (2012). Do medical marijuana laws increase marijuana use? Replication study and extension. Annals of Epidemiology, 22, 207–212.CrossRefPubMed

Harrison, L., Martin, S., Enev, T., & Harrington, D. (2007). Comparing drug testing and self-report of drug use among youths and young adults in the general population (DHHS Publication No. SMA 07-4249, Methodology Series M-7). Rockville: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.

Hasin, D. S., & Grant, B. (2016). NESARC findings on increased prevalence of marijuana use disorders—consistent with other sources of information. JAMA Psychiatry, 73, 532.CrossRefPubMedPubMedCentral

Hasin, D. S., Keyes, K. M., Alderson, D., Wang, S., Aharonovich, E., & Grant, B. F. (2008). Cannabis withdrawal in the United States: Results from NESARC. Journal of Clinical Psychiatry, 69, 1354–1363.CrossRefPubMed

Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., et al. (2015a). Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013. JAMA Psychiatry, 72, 1235–1242.CrossRefPubMedPubMedCentral

Hasin, D. S., Wall, M., Keyes, K. M., Cerdá, M., Schulenberg, J., O'Malley, P. M., et al. (2015b). Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: Results from annual, repeated cross-sectional surveys. Lancet Psychiatry, 2, 601–608.CrossRefPubMedPubMedCentral

Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, H., et al. (2016). Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. American Journal of Psychiatry, 173, 588–599.CrossRefPubMed

Hunter, S., Feder, M., Granger, B., Piper, L., Chromy, J. (2005). 2005 National Survey on Drug Use and Health, Reliability study pretest analysis. Research Triangle Park: Prepared for the Substance Abuse and Mental Health Services Administration, Office of Applied Studies, under Contract No. 283–2004-00022, RTI/0209009.

Jager, G., & Ramsey, N. F. (2008). Long-term consequences of adolescent cannabis exposure on the development of cognition, brain structure and function: An overview of animal and human research. Current Drug Abuse Reviews, 1, 114–123.CrossRefPubMed

Kim, J. H., Santaella-Tenorio, J., Mauro, C., Wrobel, J., Cerdá, M., Keyes, et al. (2016). State medical marijuana laws and the prevalence of opioids detected among fatally injured drivers. American Journal of Public Health, 106, 2032–2037.

Lin, L. A., Ilgen, M. A., Jannausch, M., & Bohnert, K. M. (2016). Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample. Addictive Behaviors, 61, 99–103.CrossRefPubMedPubMedCentral

Lynne-Landsman, S. D., Livingston, M. D., & Wagenaar, A. C. (2013). Effects of state medical marijuana laws on adolescent marijuana use. American Journal of Public Health, 103, 1500–1506.CrossRefPubMedPubMedCentral

Lynskey, M., & Hall, W. (2000). The effects of adolescent cannabis use on educational attainment: A review. Addiction, 95, 1621–1630.CrossRefPubMed

Martins, S. S., Mauro, C. M., Santaella-Tenorio, J., Kim, J. H., Cerda, M., Keyes, K. M., et al. (2016). State-level medical marijuana laws, marijuana use and perceived availability of marijuana among the general U.S. population. Drug and Alcohol Dependence, 169, 26–32.CrossRefPubMedPubMedCentral

Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S., et al. (2012). Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences, 109(40), E2657–E2664.CrossRef

Morral, A. R., McCaffrey, D. F., & Chien, S. (2003). Measurement of adolescent drug use. Journal of Psychoactive Drugs, 35, 301–309.CrossRefPubMed

National Conference of State Legislatures. (2016). Marijuana overview. Retrieved from http://www.ncsl.org/research/civil-and-criminal-justice/marijuana-overview.aspx. Accessed 1 Nov 2016.

Nussbaum, A. M., Thurstone, C., McGarry, L., Walker, B., & Sabel, A. L. (2015). Use and diversion of medical marijuana among adults admitted to inpatient psychiatry. The American Journal of Drug and Alcohol Abuse, 41, 166–172.CrossRefPubMed

Pacek, L. R., Mauro, P. M., & Martins, S. S. (2015). Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity. Drug and Alcohol Dependence, 149, 232–244.CrossRefPubMedPubMedCentral

Pacula, R. L., & Sevigny, E. L. (2014). Marijuana liberalization policies: Why we can’t learn much from policy still in motion. Journal of Policy Analysis and Management, 33, 212–221.CrossRefPubMedPubMedCentral

Pacula, R., Hunt, P., & Boustead, A. (2014). Words can be deceiving: A review of variation among legally effective medical marijuana laws in the United States. Journal of Drug Policy Analysis, 7, 1–19.CrossRefPubMedPubMedCentral

Pew Research Center. (2014). America’s new drug policy landscape. U.S. politics & policy. Retrieved from: http://www.people-press.org/2014/04/02/americas-new-drug-policy-landscape/. Accessed 1 Nov 2016.

Piper, L., Meyer, M., Snodgrass, J. (2006). Reliability study pretest final report. Rockville: Prepared for Substance Abuse and Mental Health Services Administration, Office of Applied Studies, under contract No. 283-2004-00022, RTI/0209009.

Powell, D., Pacula, R.L., Jacobson, M. (2015). Do medical marijuana laws reduce addictions and deaths related to pain killers? RAND corporation, WR-1130. Retrieved from: http://www.rand.org/pubs/working_papers/WR1130.html. Accessed 1 Nov 2016.

ProCon.org (2016). Legal medical marijuana states and DC: Laws, fees, and possession limits. Retrieved from: http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881. Accessed 1 Nov 2016.

Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6, 1–5.CrossRef

Reinarman, C., Nunberg, H., Lanthier, F., & Heddleston, T. (2011). Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs, 43(2), 128–135.CrossRefPubMed

Ryan, C., Bauman, K. (2016). Educational attainment in the United States: 2015. U.S. Department of Commerce, U.S. Census Bureau. Retrieved from: https://www.census.gov/content/dam/Census/library/publications/2016/demo/p20-578.pdf. Accessed 1 Nov 2016.

Santaella-Tenorio, J., Mauro, C., Wall, M. M., Kim, J. H., Cerdá, M., Keyes, K. M., et al. (2017). US traffic fatalities, 1985-2014, and their relationship to medical marijuana Laws. American Journal of Public Health, 107, 336–342.CrossRefPubMedPubMedCentral

Scavone, J. L., Sterling, R. C., & Van Bockstaele, E. J. (2013). Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal. Neuroscience, 248, 637–654.CrossRefPubMed

Substance Abuse and Mental Health Services Administration. (2014). Behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health (HHS Publication No. SMA 15-4927, NSDUH Series H-50). Rockville, MD: Center for Behavioral Health Statistics and Quality Retrieved from: https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.pdf. Accessed 1 Nov 2016.

Substance Abuse and Mental Health Data Archive. (2017). National Survey on Drug Use and Health (NSDUH) [Data files]. U.S. Department of Health and Human Services. Retrieved from: http://www.datafiles.samhsa.gov/study-series/national-survey-drug-use-and-health-nsduh-nid13517. Accessed 15 July 2015.

Tashkin, D. P., Baldwin, G. C., Sarafian, T., Dubinett, S., & Roth, M. D. (2002). Respiratory and immunologic consequences of marijuana smoking. Journal of Clinical Pharmacology, 42, 71S–81S.CrossRefPubMed

Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Archives of Internal Medicine, 167, 221–228.CrossRefPubMedPubMedCentral

Thornton, L. K., Baker, A. L., Johnson, M. P., & Lewin, T. (2013). Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders. Addictive Behaviors, 38(6), 2246–2251.CrossRefPubMed

van der Pol, P., Liebregts, N., de Graaf, R., Korf, D. J., van den Brink, W., & van Laar, M. (2013). Predicting the transition from frequent cannabis use to cannabis dependence: A three-year prospective study. Drug and Alcohol Dependence, 133, 352–359.CrossRefPubMed

Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. (2014). Adverse health effects of marijuana use. New England Journal of Medicine, 370, 2219–2227.CrossRefPubMed

Wall, M. M., Mauro, C., Hasin, D. S., Keyes, K. M., Cerdá, M., Martins, S. S., & Feng, T. (2016). Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011. The International Journal on Drug Policy, 29, 9–13.CrossRefPubMedPubMedCentral

Wen, H., Hockenberry, J. M., & Cummings, J. R. (2015). The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances. Journal of Health Economics, 42, 64–80.CrossRefPubMed

Williams, A. R., Santaella-Tenorio, J., Mauro, C. M., Levin, F. R., & Martins, S. S. (2017). Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder. Addiction. https://doi.org/10.1111/add.13904.

Titel: Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004–2013
verfasst von: Christine M. Mauro
Paul Newswanger
Julian Santaella-Tenorio
Pia M. Mauro
Hannah Carliner
Silvia S. Martins
Publikationsdatum: 04.11.2017
Verlag: Springer US
Erschienen in: Prevention Science / Ausgabe 2/2019
Print ISSN: 1389-4986
Elektronische ISSN: 1573-6695
DOI: https://doi.org/10.1007/s11121-017-0848-3

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004–2013

Abstract

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Race/Ethnicity Differences in Trends of Marijuana, Cigarette, and Alcohol Use Among 8th, 10th, and 12th Graders in Washington State, 2004–2016

Marijuana Promotion Online: an Investigation of Dispensary Practices

Marijuana Use among Adolescents and Emerging Adults in the Midst of Policy Change: Introduction to the Special Issue

Addendum to “The Effect of Medical Marijuana Laws on Marijuana-Related Attitude and Perception among US Adolescents and Young Adults”

The Interplay Between Marijuana-Specific Risk Factors and Marijuana Use Over the Course of Adolescence

The Impact of the Urban Neighborhood Environment on Marijuana Trajectories During Emerging Adulthood